公开(公告)号：US20230250079A1

公开(公告)日：2023-08-10

申请号：US18001464

申请日：2021-06-10

Applicant: LEO PHARMA A/S

Inventor： Mark ANDREWS ,  Morten Dahl SØRENSEN ,  Mogens LARSEN ,  Nicolas DEVAUX ,  Vinicius BARROS RIBEIRO DA SILVA ,  Quentin PERRON ,  Xifu LIANG ,  Jimmi Gerner SEIZBERG

IPC: C07D401/14 ,  C07D413/14 ,  C07D405/14 ,  C07D403/12

CPC classification number: C07D401/14 ,  C07D413/14 ,  C07D405/14 ,  C07D403/12

Abstract: The present disclosure relates to a compound according to formula I




and pharmaceutically acceptable salts, hydrates, or solvates thereof. The disclosure further relates to said compounds for use in therapy, to pharmaceutical compositions comprising said compounds, to methods of treating diseases, e.g. dermal diseases, with said compounds, and to the use of said compounds in the manufacture of medicaments.